Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 186 member A (FAM186A) is a protein-coding gene of yet unknown function in humans. Recent genomic and transcriptomic studies implicate FAM186A in cancer biology, with coding variants associated with increased colorectal cancer risk and expression changes seen during hepatocellular carcinoma progression, yet its precise molecular or cellular role is uncharacterized. It is not an established receptor, enzyme, or therapeutic target, nor is it presently classified in any major molecular target family, and no drugs or known ligands interact with it at this time[1][2][3][4][5].\n\nFAM186A is cataloged in major genetic databases (HGNC: 26980, NCBI Gene: 121006, Ensembl: ENSG00000185958, UniProt: A6NE01)[3][4]. Current evidence suggests research relevance in disease genomics, especially oncology, but not therapeutic biology.
None identified
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 186 member A (FAM186A).